Man Shing Wong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Man Shing Wong has a total of 437 co-authors. Here are the top co-authors by number of shared publications:
- Hung-Wing Li
Department of Chemistry, The Chinese University of Hong Kong, Hong Kong, China
26 shared publications - Zhong Hui Li
College of Chemistry and Life Science, Sichuan Provincial Key Laboratory for Structural Optimization and Application of Functional Molecules, Chengdu Normal University, Chengdu, 611130, China
21 shared publications Christian Bosshard
Nonlinear Optics Laboratory, Institute of Quantum Electronics, Swiss Federal Institute of Technology (ETH), CH-8093 Zurich, Switzerland, and Institute of Polymers, Department of Materials, ETH, CH-8092 Zurich, Switzerland
18 shared publicationsDi Xu
Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, SAR China
17 shared publicationsLei Guo
School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China
17 shared publicationsPeter Günter
Nonlinear Optics Laboratory, Institute of Quantum Electronics, Swiss Federal Institute of Technology (ETH), CH-8093 Zurich, Switzerland, and Institute of Polymers, Department of Materials, ETH, CH-8092 Zurich, Switzerland
17 shared publications
Latest Publications
- Open Access
- 14 June 2026
- Published by Elsevier in SSRN Electronic Journal
Multifunctional Tau-Targeted Theranostic Agent for Early Diagnosis and Autophagy-Mediated Therapy in Alzheimer’s Disease
Neurofibrillary tangles (NFTs), pathological hyperphosphorylated tau aggregates, are closely correlated with cognitive decline of Alzheimer's disease (AD), serving as an important target for early diagnosis and therapy. However, the structural similarity between NFTs and amyloid-β (Aβ) fibrils poses significant challenges for tau selective detection. We present herein the development of novel multifunctional theranostic tau-targeted cyanines for in vitro and in vivo selective near-infrared imaging of NFTs and activation of autophagy-lysosomal pathway (ALP) to promote the clearance of NFTs. These cyanines showed superior binding and selectivity toward tau over Aβ fibrils, particularly o-SFVPM with a selectivity index of 5.74. Molecular docking of these cyanines with a 6-mer fibril model revealed that they entrapped inside the tunnel of tau model through hydrogen bonds and hydrophobic interactions. Because of its superior binding and selectivity toward tau fibrils and good blood-brain barrier permeability, o-SFVPM was highly viable for in vivo imaging of NFTs in different age groups of tau transgenic P301S mice. Furthermore, in vitro fluorescence staining of brain sections of 3xTg-AD mouse model further confirmed the excellent sensitivity and specificity of o-SFVPM toward NFTs over Aβ plaques. Remarkably, o-SFVPM could also serve as a transcription factor EB (TFEB) activator to induce TFEB-dependent ALP for promoting the degradation and clearance of abnormal tau aggregates in a cell model, offering promising therapeutic potential for AD. Our results underscored the unique theranostic capabilities of o-SFVPM as an effective tau-targeted probe and TFEB activator for early diagnosis and therapeutic intervention in AD.
- 14 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMultifunctional Tau-Targeted Theranostic Agent for Early Diagnosis and Autophagy-Mediated Therapy in Alzheimer’s Disease
Neurofibrillary tangles (NFTs), pathological hyperphosphorylated tau aggregates, are closely correlated with cognitive decline of Alzheimer's disease (AD), serving as an important target for early diagnosis and therapy. However, the structural similarity between NFTs and amyloid-β (Aβ) fibrils poses significant challenges for tau selective detection. We present herein the development of novel multifunctional theranostic tau-targeted cyanines for in vitro and in vivo selective near-infrared imaging of NFTs and activation of autophagy-lysosomal pathway (ALP) to promote the clearance of NFTs. These cyanines showed superior binding and selectivity toward tau over Aβ fibrils, particularly o-SFVPM with a selectivity index of 5.74. Molecular docking of these cyanines with a 6-mer fibril model revealed that they entrapped inside the tunnel of tau model through hydrogen bonds and hydrophobic interactions. Because of its superior binding and selectivity toward tau fibrils and good blood-brain barrier permeability, o-SFVPM was highly viable for in vivo imaging of NFTs in different age groups of tau transgenic P301S mice. Furthermore, in vitro fluorescence staining of brain sections of 3xTg-AD mouse model further confirmed the excellent sensitivity and specificity of o-SFVPM toward NFTs over Aβ plaques. Remarkably, o-SFVPM could also serve as a transcription factor EB (TFEB) activator to induce TFEB-dependent ALP for promoting the degradation and clearance of abnormal tau aggregates in a cell model, offering promising therapeutic potential for AD. Our results underscored the unique theranostic capabilities of o-SFVPM as an effective tau-targeted probe and TFEB activator for early diagnosis and therapeutic intervention in AD.
- 22 January 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 298, 118430
Ultrasensitive extracellular vesicles-associated amyloid-β1-42 oligomers analytical platform for early diagnosis of Alzheimer's disease
- 22 January 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 298, 118430
Ultrasensitive extracellular vesicles-associated amyloid-β1-42 oligomers analytical platform for early diagnosis of Alzheimer's disease
- Open Access
- 19 November 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (47) , 26024-26033
Space-Confined Hydrogel Particle-Based Biosensor for Early Warning of Aflatoxin B1 via Rapid Label-Free Fluorescence Detection of the afl D Gene
Aflatoxin B1 (AFB1), produced by the Aspergillus species, is one of the most potent carcinogens, posing significant health risks through contamination of food supplies. Monitoring an aflatoxin biosynthesis gene such as the aflD gene provides an early warning mechanism to prevent contamination. However, traditional methods for gene detection have limitations, including the need for sophisticated equipment and slow reaction kinetics, making them unsuitable for rapid and on-site testing. To address these challenges, we developed a novel biosensing platform based on space-confinement mechanisms using hydrogel particle arrays for the detection of the aflD gene. This system confines reactants within the outer water layer of poly(ethylene glycol) carboxylate (PEG-COOH) hydrogel particles, significantly enhancing reaction kinetics by increasing local concentrations of the aflD gene. By incorporating graphene oxide to reduce background interference, the platform further improves detection specificity. The fluorescent probe used in this platform is a newly synthesized V-shaped dicationic fluorophore (VLM), which binds selectively to double-stranded DNA (dsDNA) and offers enhanced fluorescence upon binding to the aflD gene. This space-confinement-enhanced system detects the aflD gene with high sensitivity and rapid response, outperforming conventional methods by accelerating detection rates up to 240 times. The biosensor achieved a detection limit of 19.05 nM and a linear range of 50-1000 nM and required only 15 s for detection. This platform exhibited excellent sensitivity and specificity for the aflD gene, with high potential for real-time, on-site monitoring.
- 19 November 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (47) , 26024-26033
Open AccessSpace-Confined Hydrogel Particle-Based Biosensor for Early Warning of Aflatoxin B1 via Rapid Label-Free Fluorescence Detection of the afl D Gene
Aflatoxin B1 (AFB1), produced by the Aspergillus species, is one of the most potent carcinogens, posing significant health risks through contamination of food supplies. Monitoring an aflatoxin biosynthesis gene such as the aflD gene provides an early warning mechanism to prevent contamination. However, traditional methods for gene detection have limitations, including the need for sophisticated equipment and slow reaction kinetics, making them unsuitable for rapid and on-site testing. To address these challenges, we developed a novel biosensing platform based on space-confinement mechanisms using hydrogel particle arrays for the detection of the aflD gene. This system confines reactants within the outer water layer of poly(ethylene glycol) carboxylate (PEG-COOH) hydrogel particles, significantly enhancing reaction kinetics by increasing local concentrations of the aflD gene. By incorporating graphene oxide to reduce background interference, the platform further improves detection specificity. The fluorescent probe used in this platform is a newly synthesized V-shaped dicationic fluorophore (VLM), which binds selectively to double-stranded DNA (dsDNA) and offers enhanced fluorescence upon binding to the aflD gene. This space-confinement-enhanced system detects the aflD gene with high sensitivity and rapid response, outperforming conventional methods by accelerating detection rates up to 240 times. The biosensor achieved a detection limit of 19.05 nM and a linear range of 50-1000 nM and required only 15 s for detection. This platform exhibited excellent sensitivity and specificity for the aflD gene, with high potential for real-time, on-site monitoring.
- Open Access
- 10 November 2025
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 37 (22) , 9361
Correction to “Hydrogen Bond–Driven N-Terminal Amyloid β Mimetics Attenuate Neurotoxic Aggregation”
[This corrects the article DOI: 10.1021/acs.chemmater.5c01589.].
- 10 November 2025
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 37 (22) , 9361
Open AccessCorrection to “Hydrogen Bond–Driven N-Terminal Amyloid β Mimetics Attenuate Neurotoxic Aggregation”
[This corrects the article DOI: 10.1021/acs.chemmater.5c01589.].
- Open Access
- 10 September 2025
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 37 (18) , 7326-7336
Hydrogen Bond–Driven N-Terminal Amyloid β Mimetics Attenuate Neurotoxic Aggregation
- 10 September 2025
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 37 (18) , 7326-7336
Open AccessHydrogen Bond–Driven N-Terminal Amyloid β Mimetics Attenuate Neurotoxic Aggregation
- Open Access
- 12 May 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (20) , 16175-16182
Direct and selective nanosensor for amyloid-β oligomers in serum for Alzheimer's disease diagnosis
The rising prevalence of Alzheimer's disease (AD) highlights an urgent need for ultra-sensitive diagnostic tools that facilitate early detection and intervention.
- 12 May 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (20) , 16175-16182
Open AccessDirect and selective nanosensor for amyloid-β oligomers in serum for Alzheimer's disease diagnosis
The rising prevalence of Alzheimer's disease (AD) highlights an urgent need for ultra-sensitive diagnostic tools that facilitate early detection and intervention.
- Open Access
- 4 February 2025
- Published by Springer Nature in Microchimica Acta
- Vol. 192 (3) , 1-11
A turn-on fluorescent immunosensor for neurodegenerative disease related neurofilament light chain protein
Neurodegenerative diseases (NDs) pose significant challenges to both longevity and quality of life, affecting millions worldwide and ranking as a major cause of global morbidity and disability. There is an urgent need for less invasive, cost-effective diagnostic methods that can reliably detect ND-related biomarkers in readily available biofluids such as serum. In response to this need, we have developed an ultra-sensitive assay that utilizes magnetic nanoparticles and a novel, tailor-made turn-on fluorescent probe named F-SPG. This innovative assay enables the detection of neurofilament light chain (NfL) at femtomolar concentrations, with a remarkable detection limit of 24 fM which is at least 18 times more sensitive than the conventional ELISA kits. Our assay’s design eliminates the need for traditional secondary antibody in immunoassay, thereby streamlining the diagnostic process. Recoveries exceeding 95% underscore the assay’s precision and reliability. It has proven effective in distinguishing Alzheimer’s Disease patients from healthy individuals by quantifying serum NfL levels, showcasing its potential as a cost-effective, ultra-sensitive tool for the early screening of neurodegenerative diseases. Graphical abstract
- 4 February 2025
- Published by Springer Nature in Microchimica Acta
- Vol. 192 (3) , 1-11
Open AccessA turn-on fluorescent immunosensor for neurodegenerative disease related neurofilament light chain protein
Neurodegenerative diseases (NDs) pose significant challenges to both longevity and quality of life, affecting millions worldwide and ranking as a major cause of global morbidity and disability. There is an urgent need for less invasive, cost-effective diagnostic methods that can reliably detect ND-related biomarkers in readily available biofluids such as serum. In response to this need, we have developed an ultra-sensitive assay that utilizes magnetic nanoparticles and a novel, tailor-made turn-on fluorescent probe named F-SPG. This innovative assay enables the detection of neurofilament light chain (NfL) at femtomolar concentrations, with a remarkable detection limit of 24 fM which is at least 18 times more sensitive than the conventional ELISA kits. Our assay’s design eliminates the need for traditional secondary antibody in immunoassay, thereby streamlining the diagnostic process. Recoveries exceeding 95% underscore the assay’s precision and reliability. It has proven effective in distinguishing Alzheimer’s Disease patients from healthy individuals by quantifying serum NfL levels, showcasing its potential as a cost-effective, ultra-sensitive tool for the early screening of neurodegenerative diseases. Graphical abstract
- Open Access
- 28 January 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 275, 117201
Peroxynitrite and amyloid-β dual-activated near-infrared theranostic probe for oxidative stress monitoring in Alzheimer's disease
- 28 January 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 275, 117201
Open AccessPeroxynitrite and amyloid-β dual-activated near-infrared theranostic probe for oxidative stress monitoring in Alzheimer's disease
- Open Access
- 9 July 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (31) , 7543-7556
Molecular engineering of a theranostic molecule that detects Aβ plaques, inhibits Iowa and Dutch mutation Aβ self-aggregation and promotes lysosomal biogenesis for Alzheimer's disease
Extracellular clustering of amyloid-β (Aβ) and an impaired autophagy lysosomal pathway (ALP) are the hallmark features in the early stages of incurable Alzheimer's disease (AD). There is a pressing need to find or develop new small molecules for diagnostics and therapeutics for the early stages of AD. Herein, we report a small molecule, namely F-SLCOOH, which can bind and detect Aβ1–42, Iowa mutation Aβ, Dutch mutation Aβ fibrils and oligomers exhibiting enhanced emission with high affinity. Importantly, F-SLCOOH can readily pass through the blood–brain barrier and shows highly selective binding toward the extracellular Aβ aggregates in real-time in live animal imaging of a 5XFAD mice model. In addition, a high concentration of F-SLCOOH in both brain and plasma of wildtype mice after intraperitoneal administration was found. The ex vivo confocal imaging of hippocampal brain slices indicated excellent colocalization of F-SLCOOH with Aβ positive NU1, 4G8, 6E10 A11 antibodies and THS staining dye, affirming its excellent Aβ specificity and targetability. The molecular docking studies have provided insight into the unique and specific binding of F-SLCOOH with various Aβ species. Importantly, F-SLCOOH exhibits remarkable anti-fibrillation properties against toxic Aβ aggregate formation of Aβ1–42, Iowa mutation Aβ, and Dutch mutation Aβ. F-SLCOOH treatment also exerts high neuroprotective functions and promotes autophagy lysosomal biogenesis in neuronal AD cell models. In summary, the present results suggest that F-SLCOOH is a highly promising theranostic agent for diagnosis and therapeutics of AD.
- 9 July 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (31) , 7543-7556
Open AccessMolecular engineering of a theranostic molecule that detects Aβ plaques, inhibits Iowa and Dutch mutation Aβ self-aggregation and promotes lysosomal biogenesis for Alzheimer's disease
Extracellular clustering of amyloid-β (Aβ) and an impaired autophagy lysosomal pathway (ALP) are the hallmark features in the early stages of incurable Alzheimer's disease (AD). There is a pressing need to find or develop new small molecules for diagnostics and therapeutics for the early stages of AD. Herein, we report a small molecule, namely F-SLCOOH, which can bind and detect Aβ1–42, Iowa mutation Aβ, Dutch mutation Aβ fibrils and oligomers exhibiting enhanced emission with high affinity. Importantly, F-SLCOOH can readily pass through the blood–brain barrier and shows highly selective binding toward the extracellular Aβ aggregates in real-time in live animal imaging of a 5XFAD mice model. In addition, a high concentration of F-SLCOOH in both brain and plasma of wildtype mice after intraperitoneal administration was found. The ex vivo confocal imaging of hippocampal brain slices indicated excellent colocalization of F-SLCOOH with Aβ positive NU1, 4G8, 6E10 A11 antibodies and THS staining dye, affirming its excellent Aβ specificity and targetability. The molecular docking studies have provided insight into the unique and specific binding of F-SLCOOH with various Aβ species. Importantly, F-SLCOOH exhibits remarkable anti-fibrillation properties against toxic Aβ aggregate formation of Aβ1–42, Iowa mutation Aβ, and Dutch mutation Aβ. F-SLCOOH treatment also exerts high neuroprotective functions and promotes autophagy lysosomal biogenesis in neuronal AD cell models. In summary, the present results suggest that F-SLCOOH is a highly promising theranostic agent for diagnosis and therapeutics of AD.